Cypress Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.91M Sell
33,397
-141
-0.4% -$27.9K 1.52% 19
2025
Q3
$6.22M Sell
33,538
-341
-1% -$58.4K 1.41% 19
2025
Q2
$5.18M Buy
33,879
+890
+3% +$137K 1.25% 22
2025
Q1
$5.47M Sell
32,989
-3,137
-9% -$491K 1.47% 20
2024
Q4
$5.33M Sell
36,126
-635
-2% -$98.4K 1.32% 22
2024
Q3
$5.96M Buy
36,761
+326
+0.9% +$51.9K 1.48% 21
2024
Q2
$5.44M Sell
36,435
-54
-0.1% -$8.03K 1.4% 22
2024
Q1
$5.88M Sell
36,489
-984
-3% -$157K 1.59% 19
2023
Q4
$5.87M Sell
37,473
-433
-1% -$66.4K 1.77% 16
2023
Q3
$5.89M Buy
37,906
+170
+0.5% +$28.1K 1.97% 13
2023
Q2
$6.28M Sell
37,736
-743
-2% -$120K 2.02% 12
2023
Q1
$5.96M Sell
38,479
-62
-0.2% -$10K 2.06% 10
2022
Q4
$6.83M Sell
38,541
-1,900
-5% -$328K 2.48% 7
2022
Q3
$6.61M Sell
40,441
-20
-0% -$3.38K 2.53% 8
2022
Q2
$7.18M Sell
40,461
-1,135
-3% -$202K 2.57% 8
2022
Q1
$7.37M Sell
41,596
-5,730
-12% -$975K 2.16% 9
2021
Q4
$8.1M Buy
47,326
+75
+0.2% +$12.3K 1.93% 10
2021
Q3
$7.63M Buy
47,251
+205
+0.4% +$35K 1.98% 12
2021
Q2
$7.75M Buy
47,046
+297
+0.6% +$49.2K 1.99% 12
2021
Q1
$7.68M Sell
46,749
-100
-0.2% -$16.2K 2.13% 11
2020
Q4
$7.37M Sell
46,849
-260
-0.6% -$38.4K 2.06% 11
2020
Q3
$7.01M Buy
47,109
+5,668
+14% +$839K 2.19% 10
2020
Q2
$5.83M Buy
41,441
+1,939
+5% +$283K 1.94% 11
2020
Q1
$5.18M Buy
39,502
+1,530
+4% +$217K 2.24% 8
2019
Q4
$5.54M Sell
37,972
-4,440
-10% -$602K 1.89% 13
2019
Q3
$5.49M Sell
42,412
-985
-2% -$130K 1.9% 15
2019
Q2
$6.04M Sell
43,397
-2,612
-6% -$362K 2.07% 13
2019
Q1
$6.43M Sell
46,009
-6,207
-12% -$831K 2.19% 10
2018
Q4
$6.74M Sell
52,216
-9,567
-15% -$1.33M 2.52% 6
2018
Q3
$8.54M Sell
61,783
-3,470
-5% -$461K 2.51% 4
2018
Q2
$7.92M Sell
65,253
-3,935
-6% -$491K 2.34% 6
2018
Q1
$8.87M Sell
69,188
-23,425
-25% -$3.17M 2.6% 4
2017
Q4
$12.9M Sell
92,613
-5,652
-6% -$787K 2.78% 5
2017
Q3
$12.8M Sell
98,265
-9,143
-9% -$1.21M 2.75% 2
2017
Q2
$14.2M Sell
107,408
-5,353
-5% -$683K 2.91% 3
2017
Q1
$14M Sell
112,761
-4,015
-3% -$480K 2.68% 3
2016
Q4
$13.5M Buy
116,776
+115
+0.1% +$13.3K 2.58% 5
2016
Q3
$13.8M Sell
116,661
-1,101
-0.9% -$134K 2.75% 4
2016
Q2
$14.3M Sell
117,762
-5,428
-4% -$617K 2.84% 3
2016
Q1
$13.3M Sell
123,190
-2,242
-2% -$232K 2.71% 2
2015
Q4
$12.9M Buy
125,432
+350
+0.3% +$35.2K 2.59% 2
2015
Q3
$11.7M Sell
125,082
-105
-0.1% -$10.2K 2.46% 5
2015
Q2
$12.2M Buy
125,187
+376
+0.3% +$37.7K 2.29% 7
2015
Q1
$12.6M Sell
124,811
-2,040
-2% -$207K 2.35% 5
2014
Q4
$13.3M Buy
126,851
+6,219
+5% +$655K 2.44% 4
2014
Q3
$12.9M Sell
120,632
-2,235
-2% -$232K 2.32% 5
2014
Q2
$12.9M Sell
122,867
-4,592
-4% -$464K 2.22% 7
2014
Q1
$12.5M Sell
127,459
-6,687
-5% -$620K 2.27% 5
2013
Q4
$12.3M Sell
134,146
-50
-0% -$4.61K 2.14% 9
2013
Q3
$11.6M Sell
134,196
-3,040
-2% -$273K 2.16% 10
2013
Q2
$11.8M Buy
+137,236
New +$11.6M 2.19% 10

Other funds holding JNJ

Cypress Asset Management's JNJ Position: Q4 2025 in Review

Cypress Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.42% in Q4 2025, selling an estimated $27.9K and leaving 33,397 shares worth $6.91M. The position accounts for 1.52% of the portfolio, ranked #19.

Cypress Asset Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.3M in Q2 2016. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Cypress Asset Management held 33,397 shares of Johnson & Johnson worth $6.91M as of Q4 2025.
  • Cypress Asset Management sold 141 Johnson & Johnson shares in Q4 2025, an estimated $27.9K.
  • Johnson & Johnson made up 1.52% of Cypress Asset Management's portfolio in Q4 2025, its #19 holding.
  • Cypress Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Cypress Asset Management's Johnson & Johnson position peaked at $14.3M in Q2 2016.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.